Drug Approval | April 20, 2022
BDR Pharmaceuticals launch Furmecil to treat advanced gastric cancer
The launch is yet another first of its kind innovation in India
The launch is yet another first of its kind innovation in India
Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19
Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age
The fund will take equity positions in India-focused healthcare and life sciences-related companies
U.S. NIAID-sponsored trial will evaluate heterologous booster regimens, including NVX-CoV2373, after primary series with current USFDA approved or emergency use authorized-vaccines
Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment
It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D
With ValGenesis VLMS, change control driven validation activities are reduced from weeks to mere hours, and the company gains faster access to detailed metrics that help reduce costs and cycle time
Subscribe To Our Newsletter & Stay Updated
